Heart failure and hypertrophic cardiomyopathy

No definition available.

Endpoint definition

FinnGen phenotype data

Filter registries None

Check pre-conditions None

diagram bullet diagram downward connector

Include endpoints

diagram bullet diagram downward connector

Check conditions

I9_HYPERTROCARDMYOP

Apply sex-specific rule None

diagram downward connector I9_HEARTFAIL_AND_HYPERTCARDIOM

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 361 138 223
Unadjusted prevalence (%) 0.14 0.09 0.20
Mean age at first event (years) 58.75 58.66 58.80

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.10 7.45 [4.16, 13.33] 1.3e-11 104
15 years 0.05 8.02 [5.17, 12.44] 1.6e-20 95
5 years - - - -
1 year - - - -

Correlations

Index endpoint: I9_HEARTFAIL_AND_HYPERTCARDIOM – Heart failure and hypertrophic cardiomyopathy
GWS hits: 4

Survival analyses between endpoints

Plot

before Heart failure and hypertrophic cardiomyopathy
after Heart failure and hypertrophic cardiomyopathy

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Heart failure and hypertrophic cardiomyopathy